Billing and Coding: Intraocular Bevacizumab (A53009) - R17 - Effective January 1, 2025

Date Posted: January 2, 2025

This Billing and Coding article has been revised and published for notice under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Effective Date: January 1, 2025

Summary of Article Changes: Revision Effective Date: 01/01/2025

Either the short and/or long code description was changed for the following code(s). Please Note: Depending on which descriptor was used, there may not be any changes to the code display in this document: 92134

Revision Effective Date: 04/01/2023
ICD-10-CM CODES THAT SUPPORT MEDICAL NECESSITY:
Added: ICD-10-CM code H16.143, H35.3131, H35.373 to Group 1 Codes

CPT/HCPCS CODES:

Deleted: HCPCS code Q5129 from Group 1 Codes

01/01/2025: At this time 21st Century Cures Act applies to new and revised LCDs which require comment and notice. This revision is to an article that is not a local coverage determination.

Visit the Noridian Billing and Coding Articles webpage to view the complete listing of Billing and Coding articles and/or access the Active, Future, or Retired articles available in the CMS MCD.

Last Updated Jan 02 , 2025